PLATINUM DISTRIBUTION IN INTRAPERITONEAL TUMORS AFTER INTRAPERITONEAL CISPLATIN TREATMENT

被引:134
作者
LOS, G
MUTSAERS, PHA
LENGLET, WJM
BALDEW, GS
MCVIE, JG
机构
[1] EINDHOVEN UNIV TECHNOL,CYCLOTRON LAB,5600 MB EINDHOVEN,NETHERLANDS
[2] FREE UNIV AMSTERDAM,DEPT PHYS,1007 MB AMSTERDAM,NETHERLANDS
[3] INTERFAC REACTOR INST,DEPT RADIOCHEM,2629 JB DELFT,NETHERLANDS
[4] NETHERLANDS CANC INST,DEPT EXPTL THERAPY,1066 CX AMSTERDAM,NETHERLANDS
关键词
D O I
10.1007/BF00686048
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The spatial distribution of platinum (Pt) in the kidney was studied by an autoradiographic technique, in which cisplatin (CDDP) was replaced by195mPt-labeled CDDP, and by proton-induced X-ray emission (PIXE). Although both studies demonstrated comparable spatial distribution patterns, PIXE had the advantage that Pt concentrations could be determined quantitatively, in contrast to the relative information obtained by the autoradiographic technique. Using PIXE, the distribution of Pt in i.p. tumors was studied after i.p. administration of CDDP. The highest Pt concentrations were always found on the periphery of tumors, indicating that the periphery was exposed to a higher drug concentration than the center. Dose was correlated to the concentration of CDDP at both the center and the periphery (r=0.99).The Pt concentration in the periphery was usually higher by a factor of 2-3 after i.p. administration than after i.v. treatment, whereas in the center of the tumor no concentration difference could be detected. The penetration depth of CDDP lay between 1 and 2 mm and was calculated from the differences in Pt concentration after i.p. and i.v. treatment. This indicates that the effective advantage of i.p. chemotherapy with CDDP in cases of cancers limited to the peritoneal cavity is accentuated at the periphery of the tumor. © 1990 Springer-Verlag.
引用
收藏
页码:389 / 394
页数:6
相关论文
共 33 条
  • [1] INTRAPERITONEAL CHEMOTHERAPY - A REVIEW
    BRENNER, DE
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (07) : 1135 - 1147
  • [2] BULGER RE, 1984, J NATL CANCER I, V73, P1235
  • [3] CARTER SK, 1982, CHEMOTHERAPIA, V1, P83
  • [4] CASPER ES, 1983, CANCER TREAT REP, V7, P235
  • [5] CHOIE DD, 1981, LAB INVEST, V44, P397
  • [6] CHOPRA S, 1982, KIDNEY INT, V21, P54, DOI 10.1038/ki.1982.8
  • [7] DEDRICK RL, 1978, CANCER TREAT REP, V2, P1
  • [8] THE DETERMINATION OF PLATINUM IN HUMAN-TISSUES WITH PIXE
    DIKHOFF, TGMH
    VANDERHEIDE, JA
    PRINS, M
    MCVIE, JG
    [J]. IEEE TRANSACTIONS ON NUCLEAR SCIENCE, 1983, 30 (02) : 1329 - 1331
  • [9] TARGET PREPARATION OF BIOLOGICAL SPECIMENS FOR SPIXE MEASUREMENTS
    DIKHOFF, TGMH
    PRINS, M
    HOFFMAN, LJB
    [J]. NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH, 1982, 197 (01): : 129 - 132
  • [10] TOPOGRAPHIC PIXE ANALYSIS OF PLATINUM LEVELS IN KIDNEY SLICES FROM CISPLATIN TREATED PATIENTS
    DIKHOFF, TGMH
    VANDERHEIDE, JA
    MCVIE, JG
    [J]. NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM INTERACTIONS WITH MATERIALS AND ATOMS, 1985, 10-1 (MAY) : 639 - 642